Notice of Correction to Eligibility Information in PAR-16-166 "Integrating Biospecimen Science Approaches into Clinical Assay Development (U01]"

Notice Number: NOT-CA-16-040

Key Dates
Release Date:   April 18, 2016

Related Announcements
PAR-16-166    

Issued by
National Cancer Institute (NCI)

Purpose

The purpose of this Notice is to correct the Eligibility information in PAR-16-166, "Integrating Biospecimen Science Approaches into Clinical Assay Development (U01)".

Part 2. Full Text of Announcement, Section III. Eligibility Information, Eligible Applicants, Eligible Organizations

Currently reads:

Foreign Institutions
Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply.
Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply.
Foreign components, as defined in the NIH Grants Policy Statement, are not allowed.

Corrected to read:

Foreign Institutions
Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply.
Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply.
Foreign components, as defined in the NIH Grants Policy Statement, are allowed.

All other aspects of this FOA remain unchanged.

Inquiries

Please direct all inquiries to:

Abhi Rao, Ph.D.
National Cancer Institute (NCI)
Telephone: 240-276-5715
Email: abhi.rao@nih.gov